Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.
Los Angeles County, the nation’s most populous county, is spearheading a comprehensive plan to tackle a $2.9 billion medical debt crisis. Hospitals are still getting on board with the project, which is helmed by the public health department.
California’s Medicaid program is testing a novel approach for people addicted to methamphetamine, cocaine, and other stimulants. For every clean urine test, they can earn money — up to $599 a year.
Two years after increasing state and local public health budgets by $300 million annually, Gov. Gavin Newsom proposes to slash the funding in the face of California’s $45 billion deficit.
In contrast to police statements, volunteer medics said they treated serious wounds as UCLA’s pro-Palestinian protest was besieged by police and counterprotesters, including some injuries that appeared to be caused by “less lethal” projectiles fired by cops.
California’s Medicaid program is relying heavily on community groups to deliver new social services to vulnerable patients, such as security deposits for homeless people and air purifiers for asthma patients. But many of these nonprofits face staffing and billing challenges and haven’t been able to deliver services effectively.
A California lawmaker wants the state to craft guidelines for how and when schoolchildren can play or exercise during extreme weather, including heat waves. The bill comes after a 12-year-old boy died after a physical education instructor told him to run as the temperature topped 90 degrees.
Facing an overdose epidemic and public fury over conditions on the streets, famously tolerant San Francisco will start requiring welfare recipients to undergo drug screening, and treatment if necessary, to receive cash public assistance.
California lawmakers have modified a psychedelic drug bill that was vetoed last year, narrowing it to allow only supervised use of psilocybin mushrooms, ecstasy, and other hallucinogens rather than decriminalize more broadly. The current bill would establish new state agencies to regulate the program.
Federal regulators face a growing challenge — how to prevent rogue health insurance agents from switching unknowing consumers’ Obamacare coverage without making the enrollment process so cumbersome that enrollment declines.
